DLX6 and schizophrenia: DLX6-AS1 expression was significantly decreased in high inflammation schizophrenia compared to low inflammation controls as well as high inflammation bipolar disorder compared to low inflammation bipolar disorder and low inflammation controls [49–55%, ANCOVA (RIN), F(4,78) = 6.44, p < 0.0002, all post hocp ≤ 0.011, Fig. 5D].